Loading...
XKRX
002720
Market cap60mUSD
Dec 05, Last price  
4,365.00KRW
1D
1.04%
1Q
-3.64%
Jan 2017
16.40%
Name

Kukje Pharma Co Ltd

Chart & Performance

D1W1MN
XKRX:002720 chart
P/E
17.08
P/S
0.57
EPS
255.63
Div Yield, %
—
Shrs. gr., 5y
0.09%
Rev. gr., 5y
7.08%
Revenues
156.46b
+15.58%
97,272,857,000103,756,103,000121,637,704,000122,564,775,000131,308,308,000104,857,016,220126,768,060,540120,461,297,420122,426,376,880117,636,991,850120,684,005,940123,310,224,120107,681,163,420111,121,601,010130,394,720,790119,745,568,740126,583,402,930135,372,690,530156,462,823,000
Net income
5.21b
P
6,143,517,0006,224,645,0006,604,140,0006,859,001,0004,313,552,000927,806,000-18,940,084,0002,125,167,000-6,932,106,230-5,942,878,860773,061,5501,092,249,3102,192,621,150-4,761,811,9502,203,001,020-1,555,791,2803,557,333,460-8,415,187,4565,205,175,000
CFO
3.94b
+10.20%
4,829,648,0009,543,098,0001,072,167,0005,977,556,000-1,550,183,00017,385,055,2901,579,978,970-4,595,893,280-61,109,660-5,080,183,75016,098,588,910786,104,14013,248,711,0703,603,683,0005,099,946,0209,597,051,8106,503,789,1303,575,183,9013,939,913,000
Dividend
Dec 27, 201828.571428 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, and other ETC products. The company was founded in 1959 and is headquartered in Seongnam, South Korea.
URL
http://www.kukjepharm.co.kr
IPO date
Dec 27, 1975
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT